Aquarius Surgical Technologies Inc.

OTCPK:AQQR.F Stock Report

Market Cap: US$715.7k

Aquarius Surgical Technologies Past Earnings Performance

Past criteria checks 0/6

Aquarius Surgical Technologies has been growing earnings at an average annual rate of 30.9%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been declining at an average rate of 25.2% per year.

Key information

30.9%

Earnings growth rate

37.9%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate-25.2%
Return on equityn/a
Net Margin-309.3%
Last Earnings Update31 Dec 2023

Recent past performance updates

No updates

Recent updates

No updates

Revenue & Expenses Breakdown
Beta

How Aquarius Surgical Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:AQQR.F Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 230-110
30 Sep 230-110
30 Jun 230-110
31 Mar 230-110
31 Dec 220-110
30 Sep 220-110
30 Jun 220-110
31 Mar 220-110
31 Dec 211-110
30 Sep 211-210
30 Jun 211-210
31 Mar 211-210
31 Dec 201-110
30 Sep 201-210
30 Jun 201-210
31 Mar 201-220
31 Dec 191-210
30 Sep 191-210
30 Jun 191-210
31 Mar 190-210
31 Dec 181-620
30 Sep 181-620
30 Jun 181-620
31 Mar 181-620
31 Dec 171-220
30 Sep 170-210
30 Jun 170-110
31 Mar 170-110
31 Dec 160000
30 Sep 160000
30 Jun 160000
31 Mar 160000
31 Dec 150000
30 Sep 150000
30 Jun 150000
31 Mar 150000
31 Dec 140000
30 Sep 140000
30 Jun 140000
31 Mar 140000
31 Dec 130000
30 Sep 130000
30 Jun 130000
31 Mar 130000

Quality Earnings: AQQR.F is currently unprofitable.

Growing Profit Margin: AQQR.F is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: AQQR.F is unprofitable, but has reduced losses over the past 5 years at a rate of 30.9% per year.

Accelerating Growth: Unable to compare AQQR.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AQQR.F is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (8.7%).


Return on Equity

High ROE: AQQR.F's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.